Actively Recruiting
Evaluation of a New Postoperative Dressing After Hallux Valgus Surgery
Led by Centre Assal for Foot Medicine and Surgery SA · Updated on 2025-12-17
40
Participants Needed
1
Research Sites
19 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hallux valgus, commonly called a bunion, is a condition where the big toe bends toward the other toes, often causing pain and difficulty wearing shoes. Surgical correction realigns the toe, but during recovery, a toe spacer is used to keep the toes properly positioned while soft tissues heal. This study evaluates whether a new custom-made 3D-printed toe spacer is better tolerated and helps maintain toe alignment compared to the standard folded-gauze spacer after bunion surgery. The trial includes 40 adults undergoing hallux valgus surgery, randomly assigned to receive either the 3D-printed spacer or the standard gauze spacer. The custom spacer is made individually for each patient using 3D printing technology and thermoplastic polyurethane, a biocompatible material used in orthopedic devices. It is placed externally between the big toe and second toe immediately after surgery and worn continuously for five weeks as part of routine postoperative care. The standard group receives the usual folded gauze spacer, also worn continuously for five weeks. Both spacers are non-invasive and applied immediately after surgery. Participants will have follow-up visits at 1 week, 3 weeks, and 5 weeks after surgery to assess comfort, pain, and any skin irritation from the spacer. At the final visit, toe alignment will be checked using routine weight-bearing X-rays and clinical examination. No extra medical procedures or radiation beyond standard care are needed. The main goal is to see if the 3D-printed spacer is better tolerated, with secondary goals assessing toe alignment and spacer-related side effects during this five-week period.
CONDITIONS
Brief Title
Evaluation of a New Postoperative Dressing After Hallux Valgus Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosis of hallux valgus requiring surgical correction
- Undergoing a standard hallux valgus procedure at the study center
- Able to comply with study procedures and follow-up visits
- Signed informed consent obtained before participation
You will not qualify if you...
- Inability to provide informed consent
- Inability to comply with study procedures or follow-up visits
- Insufficient language comprehension for study instructions
- Bilateral hallux valgus surgery planned
- Known allergy or hypersensitivity to thermoplastic polyurethane (TPU)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day
Participants undergo hallux valgus surgical correction and receive a postoperative toe spacer applied immediately after surgery as part of routine care.
1 visit (in-person)
Duration - 5 weeks
Participants are monitored for tolerance of the toe spacer and alignment outcomes through clinical evaluation and patient-reported comfort and pain scores.
3 visits at 1, 3, and 5 weeks after surgery (in-person)
Trial Site Locations
Total: 1 location
1
Centre Assal de médecin et chirurgie du pied
Geneva, Canton of Geneva, Switzerland, 1206
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2